Centripetal Networks, LLC v. Keysight Technologies, Inc.

Court of Appeals for the Federal Circuit·Decided April 2, 2026·No. 24-2246·Unpublished

Opinion

Case: 24-2246 Document: 41 Page: 1 Filed: 04/02/2026

NOTE: This disposition is nonprecedential.

United States Court of Appeals for the Federal Circuit ______________________

CENTRIPETAL NETWORKS, LLC, Appellant

v.

KEYSIGHT TECHNOLOGIES, INC., Appellee ______________________

2024-2246 ______________________

Appeal from the United States Patent and Trademark Office, Patent Trial and Appeal Board in No. IPR2022- 01525. ______________________

Decided: April 2, 2026 ______________________

DANIEL NOAH LERMAN, Herbert Smith Freehills Kra- mer (US) LLP, Washington, DC, argued for appellant. Also represented by PAUL J. ANDRE, CHRISTINA M. FINN, JAMES R. HANNAH, Redwood Shores, CA.

GERARD M. DONOVAN, Reed Smith LLP, Washington, DC, argued for appellee. Also represented by PETER J. CHASSMAN, MICHAEL JOHN FORBES, Houston, TX; JONATHAN IAIN MAX DETRIXHE, JONAH D. MITCHELL, San Case: 24-2246 Document: 41 Page: 2 Filed: 04/02/2026

Francisco, CA; JAMES CHRISTOPHER MARTIN, Pittsburgh, PA. ______________________

Before LOURIE and PROST, Circuit Judges, and BURROUGHS, District Judge. 1 LOURIE, Circuit Judge. Centripetal Networks, LLC (“Centripetal”) appeals from a final written decision of the United States Patent Trial and Appeal Board (“the Board”) determining that claims 1–20 of its U.S. Patent 10,284,526 (“the ’526 patent”) are unpatentable as anticipated or obvious in an inter partes review. Keysight Techs., Inc. v. Centripetal Networks, LLC, No. IPR2022-01525 (P.T.A.B. Apr. 15, 2024) (“Decision”), J.A. 1–66. For the following reasons, we affirm. BACKGROUND Centripetal’s ’526 patent is directed to methods and systems of network security using efficient decryption. See ’526 patent at Abstract. Specifically, the ’526 patent dis- closes methods of selectively decrypting packets of data, in- specting the contents of the packets, performing further action depending on the contents of the packets, and then transmitting the packets to their destinations. See id. Keysight Technologies, Inc. (“Keysight”) filed a petition for inter partes review, challenging all claims of the ’526 patent, J.A. 102–84, which the Board granted, J.A. 267– 330. The Board determined that claim 1, which is repre- sentative for purposes of this appeal, is unpatentable on four grounds: (1) anticipated by Cisco IronPort AsyncOS

1 Honorable Allison D. Burroughs, District Judge, United States District Court for the District of Massachu- setts, sitting by designation. Case: 24-2246 Document: 41 Page: 3 Filed: 04/02/2026

CENTRIPETAL NETWORKS, LLC v. 3 KEYSIGHT TECHNOLOGIES, INC.

7.1 for Web User Guide (“IPUG”), (2) anticipated by U.S. Patent Application 2012/0290829 (“Altman”), (3) obvious over IPUG, and (4) obvious over Altman in combination with U.S. Patent Application 2015/0121449 (“CP”). Deci- sion, J.A. 66. Centripetal timely appealed. We have jurisdiction un- der 28 U.S.C. § 1295(a)(4)(A). DISCUSSION Centripetal challenges all of the Board’s grounds for determining that the claims of the ’526 patent are un- patentable. We address only the ground that IPUG antici- pates claim 1 because, as we are affirming the Board on that ground, the other grounds are moot. Centripetal ar- gues that the Board erred in construing claim 1 and deter- mining that IPUG was a printed publication available before the ’526 patent’s priority date. “We review claim construction de novo except for sub- sidiary fact findings, which we review for substantial evi- dence.” Acceleration Bay, LLC v. Activision Blizzard, Inc., 908 F.3d 765, 769 (Fed. Cir. 2018). Anticipation and the scope and content of prior art are questions of fact that we review for substantial evidence. In re Chudik, 851 F.3d 1365, 1371 (Fed. Cir. 2017); Teva Pharms. USA, Inc. v. Cor- cept Therapeutics, Inc., 18 F.4th 1377, 1382 (Fed. Cir. 2021) (citation omitted). Substantial evidence is “such relevant evidence as a reasonable mind might accept as adequate to support a conclusion.” Consolidated Edison Co. of N.Y. v. Nat’l Lab. Rels. Bd., 305 U.S. 197, 229 (1938). In relevant part, claim 1 recites: [R]eceiving . . . one or more packets initiating at least one encrypted communication flow; . . . de- crypting . . . each packet of an encrypted communi- cation flow . . . and performing a corresponding action on each packet of the encrypted communica- tion flow[;] . . . and re-encrypting, after performing Case: 24-2246 Document: 41 Page: 4 Filed: 04/02/2026

the corresponding action, each packet of the en- crypted communication flow . . . and transmitting each packet of the encrypted communication flow to its intended destination. ’526 patent col. 17 l. 63–col. 18 l. 21 (emphasis added). The Board determined that the claimed “‘correspond- ing action’ includes any action, including the action of al- lowing a further transmission of a packet, without any further action.” Decision, J.A. 13. We agree. Neither claim 1 nor the ’526 patent’s specification limits the “correspond- ing action” to any particular type of action, nor do they in- dicate that allowing a packet to proceed cannot be a “corresponding action.” In fact, the specification provides exemplary “actions,” including “blocking” a packet. ’526 patent col. 6 l. 62–col. 7 l. 1. As the Board explained, “al- lowing” a packet is the opposite of “blocking” a packet and would naturally also be considered an “action.” See Deci- sion, J.A. 12. Centripetal argues that this claim construction is in- correct because it renders another claim limitation, “trans- mitting each packet of the encrypted communication flow to its intended destination,” superfluous. Open. Br. at 28– 31. We disagree. As the Board explained, “the further steps of re-encrypting and transmitting the packet . . . are taken ‘after performing the corresponding action,’ e.g., af- ter allowing the packet, and are presumed to be of different scope from the allowing action” step. Decision, J.A. 13. That is, under this construction, a “corresponding action” of allowing a packet to proceed to the next step of “re-en- cryption” would necessarily happen before, and be different from, the final step of “transmitting each packet of the en- crypted communication flow to its intended destination.” Indeed, the Board explained that the “corresponding action” and “transmitting each packet” steps were “of dif- ferent scope” and then found that IPUG disclosed both lim- itations. See Decision, J.A. 13, 29–32. The Board found Case: 24-2246 Document: 41 Page: 5 Filed: 04/02/2026

CENTRIPETAL NETWORKS, LLC v. 5 KEYSIGHT TECHNOLOGIES, INC.

that IPUG’s “blocking, redirecting, or allowing the packet (with or without logging it or taking any other action)” dis- closes the “corresponding action,” and then determined that IPUG also discloses “[r]e-encrypting and transmit- ting.” Decision, J.A. 32. That determination is supported by substantial evidence. IPUG discloses that “[a]ccess po- lices are applied to the decrypted traffic,” which could re- sult in one of three actions: “[a]llow,” “[b]lock,” or “[r]edirect” the traffic. J.A. 1490, 1536–37. Then, “[a]ssuming the [a]ccess [p]olicy group allows the client to receive the data, the data is encrypted,” and then the “[e]ncrypted data is sent to the client.” J.A. 1537.

Free access — add to your briefcase to read the full text and ask questions with AI

Centripetal Networks, LLC v. Keysight Technologies, Inc., (Fed. Cir. 2026).

Centripetal Networks, LLC v. Keysight Technologies, Inc. (Centripetal Networks, LLC v. Keysight Technologies, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

In Re: Chudik
851 F.3d 1365 (Federal Circuit, 2017)
Acceleration Bay, LLC v. Activision Blizzard Inc.
908 F.3d 765 (Federal Circuit, 2018)
Teva Pharmaceuticals USA v. Corcept Therapeutics, Inc.
18 F.4th 1377 (Federal Circuit, 2021)